Zn‐MOF‐74 as pH‐Responsive Drug‐Delivery System of Arsenic Trioxide
Source abstract
Abstract
Abstract Although arsenic and its compounds are mainly known as a poison, they also found applications as drugs in medicine. However, their distribution in a therapeutic dose is often problematic due to their high toxicity. One possibility how to address this issue is utilizing drug‐delivery systems. Herein, we report on a metal‐organic framework (MOF) called Zn‐MOF‐74, which comprises Zn(II) ions and 2,5‐dihydroxybenzene‐1,4‐dicarboxylate ligands, as a drug nanocarrier of arsenic trioxide. We synthetized the material in a nanoparticle formulation and showed that due to the open metal sites in Zn‐MOF‐74, it was possible to load the material with a high amount of the As(III)‐drug (in a form of arsenous acid). Moreover, we also investigated the drug release at different pH values. Noticeably, we observed that the As(III)‐release was pH‐triggered and was faster at pH 6.0 than at pH 7.4. Therefore, we suggest Zn‐MOF‐74 as a model example of a MOF containing open metal sites for controlled drug loading and delivery.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Arsenic contamination and mitigation · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Chair of Solid State and Materials Chemistry Institute of Physics University of Augsburg Universitaetsstraße 1 D-86159 Augsburg Germany
References (73)
Show source-provided references
1. Akhtar A. · J. Biomed. Res. · 2017 · 31 · 17710.7555/JBR.31.20160059 ↗
2. 10.1111/j.1365-2141.2009.07623.x10.1111/j.1365-2141.2009.07623.x ↗
3. 10.1097/00001813-200502000-0000210.1097/00001813-200502000-00002 ↗
4. 10.1021/ic401211u10.1021/ic401211u ↗
5. European Medical Agency (EMA) Trisenox EMEA/H/C000388/II/0058 assessment report 2016.
6. 10.1002/ijc.2871910.1002/ijc.28719 ↗
7. 10.1158/1078-0432.CCR-10-006810.1158/1078-0432.CCR-10-0068 ↗
8. 10.1186/1472-6750-9-8410.1186/1472-6750-9-84 ↗
9. 10.1186/s12951-018-0392-810.1186/s12951-018-0392-8 ↗
10. 10.1016/j.jare.2018.06.00510.1016/j.jare.2018.06.005 ↗
11. 10.1016/j.cbpa.2005.10.00510.1016/j.cbpa.2005.10.005 ↗
12. 10.1039/C5BM00532A10.1039/C5BM00532A ↗
13. 10.1517/17425247.2013.74750710.1517/17425247.2013.747507 ↗
14. 10.4155/tde.12.2110.4155/tde.12.21 ↗
15. Sercombe L. · Front Physiol. · 2015 · 6 · 286
16. 10.3390/nano707018910.3390/nano7070189 ↗
17. 10.1002/mabi.20130025010.1002/mabi.201300250 ↗
18. 10.1021/ac501293e10.1021/ac501293e ↗
19. 10.1007/s40242-014-3306-910.1007/s40242-014-3306-9 ↗
20. 10.1177/088532821663721110.1177/0885328216637211 ↗
21. 10.1016/j.colsurfb.2014.09.04610.1016/j.colsurfb.2014.09.046 ↗
22. 10.1002/chem.20190259910.1002/chem.201902599 ↗
23. 10.1039/C8TB01899E10.1039/C8TB01899E ↗
24. 10.1002/anie.20030063610.1002/anie.200300636 ↗
25. 10.1021/ja305563910.1021/ja3055639 ↗
26. 10.1016/j.mattod.2017.07.00610.1016/j.mattod.2017.07.006 ↗
27. 10.1021/acs.chemrev.7b0009110.1021/acs.chemrev.7b00091 ↗
28. 10.1002/adma.20170366310.1002/adma.201703663 ↗
29. 10.1002/celc.20170093110.1002/celc.201700931 ↗
30. 10.1021/cr200324t10.1021/cr200324t ↗
31. 10.1039/C7CS90049J10.1039/C7CS90049J ↗
32. 10.1517/17425247.2013.74158310.1517/17425247.2013.741583 ↗
33. M. Mozafari Metal-Organic Frameworks for Biomedical Applications; Woodhead Publishing 2020.
34. 10.1039/c2dt30357d10.1039/c2dt30357d ↗
35. 10.1002/advs.20180152610.1002/advs.201801526 ↗
36. 10.1002/asia.20180122110.1002/asia.201801221 ↗
37. 10.1002/adfm.20180283010.1002/adfm.201802830 ↗
38. 10.1039/C6SC01359G10.1039/C6SC01359G ↗
39. 10.1038/nmat260810.1038/nmat2608 ↗
40. 10.1039/C7CE02053H10.1039/C7CE02053H ↗
41. 10.1021/ja045123o10.1021/ja045123o ↗
42. 10.1002/ejic.20070128410.1002/ejic.200701284 ↗
43. 10.1021/ja807023q10.1021/ja807023q ↗
44. 10.1166/jnn.2010.149310.1166/jnn.2010.1493 ↗
45. 10.1002/anie.20050150810.1002/anie.200501508 ↗
46. 10.1002/ange.20050150810.1002/ange.200501508 ↗
47. 10.1039/b515434k10.1039/b515434k ↗
48. 10.1039/C2DT32138F10.1039/C2DT32138F ↗
49. 10.1021/cm502760q10.1021/cm502760q ↗
50. 10.1021/cm402897c10.1021/cm402897c ↗
51. 10.1021/ja205976v10.1021/ja205976v ↗
52. 10.1039/C8RE00228B10.1039/C8RE00228B ↗
53. 10.1039/C7TB02970E10.1039/C7TB02970E ↗
54. Hu Q. · J. Med. Chem. · 2014 · 57 · 13
55. 10.1038/s41467-018-03650-w10.1038/s41467-018-03650-w ↗
56. Sigma-Aldrich: http://www.sigmaaldrich.com/ (accessed Apr 2020).
57. Kuriyama I. · Mol. Med. · 2013 · 8 · 535
58. 10.1021/np50059a03010.1021/np50059a030 ↗
59. 10.1016/j.addr.2010.04.00910.1016/j.addr.2010.04.009 ↗
60. 10.1021/acsanm.8b0050110.1021/acsanm.8b00501 ↗
61. Mohan D. · J. Hazard. Mater. · 2007 · 142
62. 10.1016/j.jssc.2018.09.04210.1016/j.jssc.2018.09.042 ↗
63. Sanchez-Sanchez M. · Green Chem. · 2015 · 17
64. 10.1021/acs.est.7b0010710.1021/acs.est.7b00107 ↗
65. 10.1366/00037026877438309310.1366/000370268774383093 ↗
66. 10.1021/ic035159210.1021/ic0351592 ↗
67. 10.1021/acs.est.7b0621210.1021/acs.est.7b06212 ↗
68. Yang J.-C. · Sci. Rep. · 2017 · 7
69. 10.1021/cm503818310.1021/cm5038183 ↗
70. 10.1016/j.tet.2008.06.03610.1016/j.tet.2008.06.036 ↗
71. Tannock I. F. · Cancer Res. · 1989 · 49 · 4373
72. 10.1107/S056774087500678410.1107/S0567740875006784 ↗
73. 10.1039/C9DT01710K10.1039/C9DT01710K ↗